Background: Oncogenic PIK3CA mutations (PIK3CAmut) frequently occur in a higher proportion in luminal breast cancer (LBC), especially in refractory advanced cases, and are associated with changes in tumour cellular metabolism. This evidence concerns the gene PIK3CA and CDH1-related diffuse gastric and lobular breast cancer syndrome.